Novonesis
Magnus Ingemann Christensen is a seasoned professional currently serving as the Global Head of Commercial Pricing & Analytics at Novonesis, where responsibilities include overseeing global pricing strategies for a nutraceutical portfolio generating over 400 million EUR annually. Previous roles include Global Business Development Manager at Novonesis, where the focus was on the commercialisation of probiotic and enzyme-based solutions, and Commercial Excellence Director at Børsen, leading strategic initiatives for digital growth. Prior experience encompasses commercial management for the Starbucks export business at Arla Foods, co-founding BYIC.dk, and various strategic consulting roles. Magnus holds a Master of Science in Business & Development Studies from Copenhagen Business School, ranking in the top 10% of the program.
This person is not in any teams
This person is not in any offices
Novonesis
43 followers
At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces. Enzymes, functional proteins and microorganisms are our planet's tiniest, yet mightiest agents of change. When we leverage their power with science, we create biosolutions that transform the way we all produce, consume and live. Today, we are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world our biosolutions already create value for thousands of customers and benefit the planet. Our solutions enable feeding and fueling the world more sustainably, from healthy and sustainable nutrition to biofuel. Biosolutions also reduce the use of fossil-based resources, chemicals, energy and water. And this is just the beginning. The potential is almost endless. The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together, we will create the change our world needs. Let’s better our world with biology.